EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias: EFNS GUIDELINES/CME ARTICLE

J. M. Burgunder, J. Finsterer, Z. Szolnoki, B. Fontaine, J. Baets, C. Van Broeckhoven, S. Di Donato, P. De Jonghe, T. Lynch, C. Mariotti, L. Schöls, A. Spinazzola, S. J. Tabrizi, C. Tallaksen, M. Zeviani, H. F. Harbo, T. Gasser

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objectives: These EFNS guidelines on the molecular diagnosis of channelopathies, including epilepsy and migraine, as well as stroke, and dementia are designed to summarize the possibilities and limitations of molecular genetic techniques and to provide diagnostic criteria for deciding when a molecular diagnostic work-up is indicated. Search strategy: To collect data about planning, conditions, and performance of molecular diagnosis of these disorders, a literature search in various electronic databases was carried out and original papers, meta-analyses, review papers, and guideline recommendations were reviewed. Results: The best level of evidence for genetic testing recommendation (B) can be found for a small number of syndromes, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, severe myoclonic epilepsy of infancy, familial recurrent hemorrhages, familial Alzheimer's disease, and frontotemporal lobar degeneration. Good practice points can be formulated for a number of other disorders. Conclusion: These guidelines are provisional, and the future availability of molecular genetic epidemiological data about the neurogenetic disorders under discussion in our article will allow improved recommendation with an increased level of evidence.

Original languageEnglish
Pages (from-to)641-648
Number of pages8
JournalEuropean Journal of Neurology
Volume17
Issue number5
DOIs
Publication statusPublished - May 2010

Fingerprint

Channelopathies
Migraine Disorders
Dementia
Epilepsy
Stroke
Guidelines
Molecular Biology
CADASIL
Frontotemporal Lobar Degeneration
Myoclonic Epilepsy
Genetic Techniques
Molecular Pathology
Genetic Testing
Meta-Analysis
Alzheimer Disease
Databases
Hemorrhage

Keywords

  • Channelopathies
  • EFNS task force
  • Migraine
  • Molecular diagnosis
  • Neurogenetic
  • Stroke

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias : EFNS GUIDELINES/CME ARTICLE. / Burgunder, J. M.; Finsterer, J.; Szolnoki, Z.; Fontaine, B.; Baets, J.; Van Broeckhoven, C.; Di Donato, S.; De Jonghe, P.; Lynch, T.; Mariotti, C.; Schöls, L.; Spinazzola, A.; Tabrizi, S. J.; Tallaksen, C.; Zeviani, M.; Harbo, H. F.; Gasser, T.

In: European Journal of Neurology, Vol. 17, No. 5, 05.2010, p. 641-648.

Research output: Contribution to journalArticle

Burgunder, JM, Finsterer, J, Szolnoki, Z, Fontaine, B, Baets, J, Van Broeckhoven, C, Di Donato, S, De Jonghe, P, Lynch, T, Mariotti, C, Schöls, L, Spinazzola, A, Tabrizi, SJ, Tallaksen, C, Zeviani, M, Harbo, HF & Gasser, T 2010, 'EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias: EFNS GUIDELINES/CME ARTICLE', European Journal of Neurology, vol. 17, no. 5, pp. 641-648. https://doi.org/10.1111/j.1468-1331.2010.02985.x
Burgunder, J. M. ; Finsterer, J. ; Szolnoki, Z. ; Fontaine, B. ; Baets, J. ; Van Broeckhoven, C. ; Di Donato, S. ; De Jonghe, P. ; Lynch, T. ; Mariotti, C. ; Schöls, L. ; Spinazzola, A. ; Tabrizi, S. J. ; Tallaksen, C. ; Zeviani, M. ; Harbo, H. F. ; Gasser, T. / EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias : EFNS GUIDELINES/CME ARTICLE. In: European Journal of Neurology. 2010 ; Vol. 17, No. 5. pp. 641-648.
@article{8b650b5356b642f68625c4471e9ca5db,
title = "EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias: EFNS GUIDELINES/CME ARTICLE",
abstract = "Objectives: These EFNS guidelines on the molecular diagnosis of channelopathies, including epilepsy and migraine, as well as stroke, and dementia are designed to summarize the possibilities and limitations of molecular genetic techniques and to provide diagnostic criteria for deciding when a molecular diagnostic work-up is indicated. Search strategy: To collect data about planning, conditions, and performance of molecular diagnosis of these disorders, a literature search in various electronic databases was carried out and original papers, meta-analyses, review papers, and guideline recommendations were reviewed. Results: The best level of evidence for genetic testing recommendation (B) can be found for a small number of syndromes, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, severe myoclonic epilepsy of infancy, familial recurrent hemorrhages, familial Alzheimer's disease, and frontotemporal lobar degeneration. Good practice points can be formulated for a number of other disorders. Conclusion: These guidelines are provisional, and the future availability of molecular genetic epidemiological data about the neurogenetic disorders under discussion in our article will allow improved recommendation with an increased level of evidence.",
keywords = "Channelopathies, EFNS task force, Migraine, Molecular diagnosis, Neurogenetic, Stroke",
author = "Burgunder, {J. M.} and J. Finsterer and Z. Szolnoki and B. Fontaine and J. Baets and {Van Broeckhoven}, C. and {Di Donato}, S. and {De Jonghe}, P. and T. Lynch and C. Mariotti and L. Sch{\"o}ls and A. Spinazzola and Tabrizi, {S. J.} and C. Tallaksen and M. Zeviani and Harbo, {H. F.} and T. Gasser",
year = "2010",
month = "5",
doi = "10.1111/j.1468-1331.2010.02985.x",
language = "English",
volume = "17",
pages = "641--648",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias

T2 - EFNS GUIDELINES/CME ARTICLE

AU - Burgunder, J. M.

AU - Finsterer, J.

AU - Szolnoki, Z.

AU - Fontaine, B.

AU - Baets, J.

AU - Van Broeckhoven, C.

AU - Di Donato, S.

AU - De Jonghe, P.

AU - Lynch, T.

AU - Mariotti, C.

AU - Schöls, L.

AU - Spinazzola, A.

AU - Tabrizi, S. J.

AU - Tallaksen, C.

AU - Zeviani, M.

AU - Harbo, H. F.

AU - Gasser, T.

PY - 2010/5

Y1 - 2010/5

N2 - Objectives: These EFNS guidelines on the molecular diagnosis of channelopathies, including epilepsy and migraine, as well as stroke, and dementia are designed to summarize the possibilities and limitations of molecular genetic techniques and to provide diagnostic criteria for deciding when a molecular diagnostic work-up is indicated. Search strategy: To collect data about planning, conditions, and performance of molecular diagnosis of these disorders, a literature search in various electronic databases was carried out and original papers, meta-analyses, review papers, and guideline recommendations were reviewed. Results: The best level of evidence for genetic testing recommendation (B) can be found for a small number of syndromes, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, severe myoclonic epilepsy of infancy, familial recurrent hemorrhages, familial Alzheimer's disease, and frontotemporal lobar degeneration. Good practice points can be formulated for a number of other disorders. Conclusion: These guidelines are provisional, and the future availability of molecular genetic epidemiological data about the neurogenetic disorders under discussion in our article will allow improved recommendation with an increased level of evidence.

AB - Objectives: These EFNS guidelines on the molecular diagnosis of channelopathies, including epilepsy and migraine, as well as stroke, and dementia are designed to summarize the possibilities and limitations of molecular genetic techniques and to provide diagnostic criteria for deciding when a molecular diagnostic work-up is indicated. Search strategy: To collect data about planning, conditions, and performance of molecular diagnosis of these disorders, a literature search in various electronic databases was carried out and original papers, meta-analyses, review papers, and guideline recommendations were reviewed. Results: The best level of evidence for genetic testing recommendation (B) can be found for a small number of syndromes, cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, severe myoclonic epilepsy of infancy, familial recurrent hemorrhages, familial Alzheimer's disease, and frontotemporal lobar degeneration. Good practice points can be formulated for a number of other disorders. Conclusion: These guidelines are provisional, and the future availability of molecular genetic epidemiological data about the neurogenetic disorders under discussion in our article will allow improved recommendation with an increased level of evidence.

KW - Channelopathies

KW - EFNS task force

KW - Migraine

KW - Molecular diagnosis

KW - Neurogenetic

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=77950898733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950898733&partnerID=8YFLogxK

U2 - 10.1111/j.1468-1331.2010.02985.x

DO - 10.1111/j.1468-1331.2010.02985.x

M3 - Article

C2 - 20298421

AN - SCOPUS:77950898733

VL - 17

SP - 641

EP - 648

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 5

ER -